Navigation Links
Personalized Medicine Makes Its Way to Pets With Cancer: Morphogenesis and SEVO-Med Team up for a Canine Cancer Field Study, First of Its Kind, Side-Effect-Free Process to Treat Companion Animals

Jacksonville, FL and Savannah, GA (PRWEB) August 23, 2013

Morphogenesis Inc., a biotechnology firm that has developed a specialized process that educates the immune system to fight cancer in dogs, cats and horses, announces the start of a field study for its personalized cancer treatment for dogs in partnership with SEVO-Med (Southeastern Veterinary Oncology and Medicine).

Tampa-based Morphogenesis and SEVO-Med, a major southeastern veterinary oncology practice which has clinics in Jacksonville and Savannah, are providing the opportunity to pet owners and veterinarians to enroll dogs with High Grade B Cell Lymphoma who might benefit from this personalized treatment.

The first 20 dogs who qualify for the study will be selected. Veterinarians and dog owners who believe their patient/pet could qualify to participate in the study should immediately contact SEVO-Med at 904-278-3870 or 912-355-5791. Once a dog is accepted into the study, treatments and study tests are provided at no cost to the owner.

The vaccine-based cancer treatments developed by Morphogenesis have been shown to manage 17 types of cancer without any side effects in canine, feline and equine patients.

In the treatment developed by Morphogenesis, the dog’s own lymphoma cells undergo a marking process that helps the animal’s immune system recognize the cells as foreign and kill them.

“We educate the body’s immune system to fight its own tumor cells,” said Pat Lawman, Ph.D., CEO of Morphogenesis. “Our process helps keep the cancer in check so that it doesn't progress, and we all think that’s a win.”

“More and more, you are seeing companion animals present with all types of cancers,” Tracy LaDue, DVM, founder of SEVO-Med, wrote in letters to veterinarians informing them of this treatment option for qualifying dogs. “The study being conducted by Morphogenesis and SEVO-Med will further demonstrate the safety and effectiveness of this cutting edge new technology in the fight against lymphoma.”    

About SEVO-Med

Southeast Veterinary Oncology (SEVO) was founded in the Jacksonville suburb of Orange Park, FL, in October, 2004 by double-board certified veterinary oncologist, Tracy LaDue, DVM. At that time, SEVO was one of the first oncology-specific veterinary specialty practices in the U.S. The practice opened its Savannah, GA, clinic in September of 2011. Today, the practices are led by Dr. LaDue and Jennifer Locke, DVM in Florida, and Andrew Daters, DVM, in Georgia. SEVO-Med’s mission is to understand the unique and special bond shared between you and your pet, to offer compassionate guidance, to deliver excellent state of the art medical care, to provide the utmost in client communication and to collaborate with referring veterinarians to develop the best therapy for your pet. For more information, please visit or call 904-278-3870 or 912-355-5791.

About Morphogenesis

Morphogenesis is a privately-held biotechnology company structured to serve the rapidly growing cell therapy, biologics and tissue engineering markets. Morphogenesis has developed a multi-indication cancer therapy which educates the immune system to attack tumor cells throughout the body without damaging other cells or systems. Its subsidiary, Veterinary Oncology Services, Inc., assists veterinary physicians in providing this non-toxic, personalized treatment for many types of cancers in cats, dogs and horses. For more information, please visit or 813-877-7896 or call 813-875-6600.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. QIAGEN Partners with Exosome Diagnostics to Create High-Performance Biofluid Sample Preparation Kits for Personalized Healthcare Research
2. The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris
3. NYSCF scientists create personalized bone substitutes from skin cells
4. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
5. Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438
6. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
7. Transplanted brain cells in monkeys light up personalized therapy
8. Research and Markets: Personalized Medicine - Scientific and Commercial Aspects - 2013 Report
9. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research, Co-Invest in Sanguine BioSciences
10. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
11. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Houston Methodist ... the Cy-Fair Sports Association to serve as their ... agreement, Houston Methodist Willowbrook will provide sponsorship support, ... connectivity with association coaches, volunteers, athletes and families. ... the Cy-Fair Sports Association and to bring Houston ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... the QB3@953 life sciences incubator to accelerate ... The shared laboratory space at QB3@953 was created to ... key obstacle for many early stage organizations - access ... the sponsorship, Amgen launched two "Amgen Golden Ticket" awards, ...
Breaking Biology Technology:
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):